MICHELLE BOMPAROLA: Open Payments
NPI 1588973838 · MINEOLA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,089 in 52 payments from 10 companies in 2025. Trend: 2023 $481 · 2024 $639 · 2025 $1,089
Food & beverage: $1,089
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $422 |
| AstraZeneca Pharmaceuticals LP | 11 | $176 |
| Amgen Inc. | 6 | $144 |
| Eisai Inc. | 4 | $81 |
| Novo Nordisk Inc | 4 | $80 |
| Astellas Pharma US Inc | 3 | $72 |
| Lilly USA, LLC | 2 | $36 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| Exact Sciences Corporation | 1 | $26 |
| Dexcom, Inc. | 1 | $24 |
Products named: CAPLYTA, AIRSUPRA, OTEZLA, Leqembi, Wegovy, Veozah, MOUNJARO, LAGEVRIO.
Industry payments across NY — which companies pay providers there.
